Maxim Affirms BiolineRx (BLRX) at 'Buy'; BL-8040 Should be Focus for Immune Oncology Segment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. NVDA
3. TSLA
4. WBD
5. AMD
6. USO
7. META
8. AMC
9. MSFT
10. ACN

Go back to Maxim Affirms BiolineRx (BLRX) at 'Buy'; BL-8040 Should be Focus for Immune Oncology Segment
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.54 +0.05 (2.01%)
Previous Close $2.49    52 Week High $1.63 
Open $2.53    52 Week Low $0.71 
Day High $2.54    P/E N/A 
Day Low $2.45    EPS $0.00 
Volume 3,310       

BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High $95.28 
Open $4.97    52 Week Low $35.37 
Day High $4.97    P/E N/A 
Day Low $4.97    EPS $-1.81 
Volume 3,145       

(NASDAQ: CLLS) Delayed: 1.54 +0.01 (0.65%)
Previous Close $1.53    52 Week High $37.55 
Open $1.53    52 Week Low $16.35 
Day High $1.55    P/E N/A 
Day Low $1.46    EPS $0.00 
Volume 34,478       

(NASDAQ: CYAD) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $59.50 
Open $84.12    52 Week Low $16.31 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $0.00 
Volume 925,927       

(NASDAQ: JUNO) Delayed: 86.96 --0 (-0%)
Previous Close $86.96    52 Week High $57.82 
Open $10.20    52 Week Low $22.37 
Day High $86.96    P/E N/A 
Day Low $86.96    EPS $0.00 
Volume 1       

(NASDAQ: KITE) Delayed: 179.79 --0 (-0%)
Previous Close $179.79    52 Week High $89.84 
Open $17.44    52 Week Low $38.41 
Day High $179.79    P/E N/A 
Day Low $179.79    EPS $0.00 
Volume 146,685